|
|
| |
Glycosylation Antibodies
|
|
|
AGL Antibody
MGAT2 Antibody
MPDU1 Antibody
|
|
Glycosylation- 61 Products
|
Legend>
|
|
Catalog #
|
Target
|
Spotlight
|
Qualification
|
Specificity
|
|
AT1060a
|
ADRM1 monoclonal antibody (M01)
|
|
ELISA,IF,S-ELISA,WB-Ce,WB-Re
|
H
|
|
AT1061a
|
ADRM1 monoclonal antibody (M02)
|
|
ELISA,WB-Ce,WB-Re
|
H
|
|
AP2402b
|
AGL Antibody (C-term)
|
|
WB, IF, E
|
H
|
|
AP2402a
|
AGL Antibody (Center)
|
|
WB, E
|
H
|
|
AP2402c
|
AGL Antibody (N-term)
|
|
IF, E
|
H
|
|
AT1120a
|
ALG12 monoclonal antibody (M06)
|
|
ELISA,S-ELISA,WB-Ce,WB-Re
|
H
|
|
AT1121a
|
ALG6 monoclonal antibody (M09)
|
|
ELISA,WB-Ce
|
H
|
|
AT1122a
|
ALG8 monoclonal antibody (M01)
|
|
ELISA,S-ELISA,WB-Re
|
H
|
|
AP2162b
|
AMFR Antibody (C-term)
|
|
WB, IHC, E
|
H, M
|
|
AP2162a
|
AMFR Antibody (N-term)
|
|
WB, IHC, E
|
H
|
|
AP2312b
|
ART3 Antibody (C-term)
|
|
WB, E
|
H
|
|
AP2312a
|
ART3 Antibody (N-term)
|
|
WB, E
|
H, M
|
|
AT1252a
|
B3GALT2 monoclonal antibody (M02)
|
|
ELISA,S-ELISA
|
H
|
|
AT1578a
|
COG2 monoclonal antibody (M01)
|
|
ELISA,WB-Ce,WB-Re
|
H
|
|
AP7430bNEW
|
COG4 Antibody (C-term)
|
|
WB, E
|
H
|
|
AT1579a
|
COG6 monoclonal antibody (M01)
|
|
ELISA,S-ELISA,WB-Ce,WB-Re
|
H
|
|
AT1580a
|
COG7 monoclonal antibody (M01)
|
|
ELISA,IF,WB-Re,WB-Tr
|
H
|
|
AT1708a
|
DAD1 monoclonal antibody (M01)
|
|
ELISA,S-ELISA
|
H
|
|
AP2403a
|
DDOST Antibody (N-term)
|
|
WB, E
|
H
|
|
AP6126a
|
EPR1 Antibody (C-term)
|
|
WB, E
|
H
|
|
AT2147a
|
GALNT6 monoclonal antibody (M01)
|
|
ELISA,RNAi-Ab,S-ELISA,WB-Ce,WB-Re,WB-Tr
|
H
|
|
AP2404b
|
GCNT1 Antibody (C-term)
|
|
WB, IHC, E
|
H
|
|
AP2404a
|
GCNT1 Antibody (Center)
|
|
WB, IHC, E
|
H, M
|
|
AP2315b
|
GCS1 Antibody (C-term)
|
|
WB, E
|
H, M
|
|
AP2315a
|
GCS1 Antibody (N-term)
|
|
WB, E
|
H
|
|
AT2235a
|
GOLGA1 monoclonal antibody (M01)
|
|
ELISA,S-ELISA,WB-Ce,WB-Re
|
H
|
|
AT2236a
|
GOLGA5 monoclonal antibody (M01)
|
|
ELISA,RNAi-Ab,S-ELISA,WB-Ce,WB-Re
|
H
|
|
AP2461b
|
GPLD1 Antibody (C-term)
|
|
WB, E
|
H
|
|
AP2405a
|
GPLD1 Antibody (N-term)
|
|
E
|
H
|
|
AP2461a
|
GPLD2 Antibody (N-term)
|
|
IHC, E
|
H
|
|
AP2729a
|
LECT1 Antibody (N-term)
|
|
WB, E
|
H
|
|
AP2406b
|
MGAT1 Antibody (C-term)
|
|
WB, IHC, E
|
H
|
|
AP2406a
|
MGAT1 Antibody (N-term)
|
|
WB, IHC, E
|
H, M
|
|
AP2407b
|
MGAT2 Antibody (C-term)
|
|
IHC, E
|
H
|
|
AP2407a
|
MGAT2 Antibody (N-term)
|
|
IHC, E
|
H
|
|
AP2411a
|
MGAT3 Antibody (N-term)
|
|
WB, IHC, E
|
H, M
|
|
AP2408a
|
MPDU1 Antibody (Center)
|
|
WB, IHC, E
|
H
|
|
AT2935a
|
MUC1 monoclonal antibody (M01)
|
|
ELISA,S-ELISA,WB-Re
|
H
|
|
AT3382a
|
POMGNT1 monoclonal antibody (M07)
|
|
ELISA,IHC-P,WB-Re
|
H
|
|
AP2538b
|
PPT1 Antibody (C-term)
|
|
WB, IHC, E
|
H
|
|
AP2538a
|
PPT1 Antibody (N-term)
|
|
WB, IHC, E
|
H, M
|
|
AT3448a
|
PSAP monoclonal antibody (M01)
|
|
ELISA,IHC-P,S-ELISA,WB-Re
|
H
|
|
AP6233a
|
RAI14 Antibody (C-term)
|
|
IHC, E
|
H
|
|
AT3558a
|
RAMP1 monoclonal antibody (M01)
|
|
ELISA,S-ELISA
|
H
|
|
AP2409b
|
Ribophorin (RPN1) Antibody (C-term)
|
|
WB, E
|
H, M
|
|
AP2409a
|
Ribophorin (RPN1) Antibody (N-term)
|
|
WB, E
|
H, M
|
|
AP2410b
|
Ribophorin 2 (RPN2) Antibody (C-term)
|
|
WB, IHC, E
|
H
|
|
AP2410a
|
Ribophorin 2 (RPN2) Antibody (N-term)
|
|
WB, IHC, E
|
H
|
|
AP1629b
|
SIGLEC11 Antibody (C-term)
|
|
IHC, E
|
H
|
|
AP1629a
|
SIGLEC11 Antibody (N-term)
|
|
IHC, E
|
H
|
|
AP1634cNEW
|
SIGLEC12 Antibody (Center)
|
|
WB, E
|
H
|
|
AP1623b
|
SIGLEC5 Antibody (C-term)
|
|
WB, E
|
H, M
|
|
AP1623a
|
SIGLEC5 Antibody (N-term)
|
|
WB, IHC, E
|
H, M
|
|
AP1625a
|
SIGLEC7 (D-siglec) Antibody (N-term)
|
|
WB, IHC, E
|
H, M
|
|
AP1627b
|
SIGLEC9 Antibody (C-term)
|
|
WB, IHC, E
|
H, M
|
|
AP1627a
|
SIGLEC9 Antibody (N-term)
|
|
IHC, E
|
H
|
|
AP2321a
|
TPST1 Antibody (N-term)
|
|
E
|
H
|
|
AT4371a
|
TRPV5 monoclonal antibody (M02)
|
|
ELISA,S-ELISA,WB-Re
|
H
|
|
AT4372a
|
TRPV5 monoclonal antibody (M06)
|
|
ELISA,WB-Ce,WB-Re
|
H
|
|
AP2422b
|
VNN2 Antibody (C-term)
|
|
E
|
H
|
|
AP2422a
|
VNN2 Antibody (N-term)
|
|
WB, E
|
H
|
|
|
|
|
Abgent has an important selection of antibodies against novel targets in the area of glycosylation. From the glycogen debrancher enzyme AGL, to the glycosyltransfereases MPDU1 and MGAT2, Abgent's expanding collection of glycosylation antibodies benefit this important research area. Review our list to choose among the quality glycosylation antibodies Abgent has to offer.
Glycosylation is a post-translational modification process that links saccharides to produce glycans, which can be free or attached to lipids and proteins. This process produces one of the four fundamental cellular components, along with nucleic acids, proteins, and lipids. Diseases associated with glycosylation defects include congenital disorders of glycosylation, (CDG), also known as carbohydrate deficient glycoprotein syndromes, and diseases associated with advanced aging.
For any questions on our products such as protein glycosylation, protein modification and autophagy, please contact a technical service representative.
|
|
Legend
|
Qualification:
ChIP
(Chromatin Immunoprecipitation)
DB
(Dot Blot)
E
(Elisa)
FC
(Flow Cytometry)
ICC
(Immunocytochemistry)
IF
(Immunofluorescence)
IHC
(Immunohistochemistry)
IP
(Immunoprecipitation)
WB
(Western Blot)
|
Specificity:
B
(Bovine), C
(Chicken), D
(Drosphilia), E
(C. Elegans), EBV
(EBV), G (Neisseria
Gonorrhoeae), H
(Human), Ha
(Hamster), M
(Mouse), P (Pig), Pr
(Monkey), R
(Rat), Rb
(Rabbit), S
(SARS), V
(Vaccinia
Virus), X
(Xenopus), Y
(Yeast), Z
(Zebrafish)
* Additional species predicted to react based on 93-100% sequence homology.
† Application validated by third-party citation.
|
|
|
|
|
